RA Capital
Status
ACTIVE
Global HQ
Boston, United States
Countries of investment
- United States
Investment stages
- Seed
- Series A
- Series B
Industries
- Health Tech
- Life Sciences
- Biotechnology
About
RA Capital Management is a Boston-based multi-stage investment firm dedicated to building and supporting life sciences companies, with a strategy rooted in deep scientific research and a commitment to advancing human health.
RA Capital Management is a Boston-based multi-stage investment firm dedicated to building and supporting life sciences companies, with a strategy rooted in deep scientific research and a commitment to advancing human health.
Investment Thesis
RA Capital Management is a Boston-based healthcare investment firm making both public and private equity investments in biotechnology, healthcare, and planetary health. With approximately $12.6 billion in AUM as of March 2025, RA Capital emphasizes scientific rigor and recently added flexible financing instruments, like royalty and hybrid equity-debt structures to support healthcare companies navigating maturity and capital constraints.
Manager's Experience
RA Capital Management, founded in 2002 by biotech veteran Richard Aldrich and biotech-focused managing partner Peter Kolchinsky, now oversees over 12.6 billion dollars in assets with a 130-strong team, demonstrating deep collective experience in healthcare and biotechnology investing.
Team
Peter Kolchinsky PhD – Managing Partner
Rajeev Shah – Managing Partner
Derek DiRocco PhD – Partner
Portfolio
Abcuro
Adagio Medical
Adcendo
Adcytherix
Adela
Affinia Therapeutics
AgriMetis
Ajax Therapeutics
Aktis Oncology
Alchemab Therapeutics
Alentis Therapeutics
Alpha-9 Oncology
AltruBio
Ambagon Therapeutics
Amplifier Therapeutics
Ansa Biotechnologies
Asher Bio
Avilar Therapeutics
Bambusa Therapeutics
Be Biopharma
BioAge
Bluejay Therapeutics
Bright Peak Therapeutics
Capacity Bio
Capstan Therapeutics
CDR-Life
CellCentric
Cerebral Therapeutics
CiVi Biopharma
Claris Bio
Commons Clinic
Convergent Therapeutics
Coritca
Curevo Vaccine
Delix Therapeutics
Diagonal Therapeutics
Dignify Therapeutics
Electra Therapeutics
Elektrofi
Element Biosciences
Empatica
Enara Bio
Evommune